Expert US stock credit rating analysis and default risk assessment to identify financial distress signals and potential investment risks in your portfolio. We monitor credit markets to understand the health of companies and potential risks to equity holders from debt obligations. We provide credit ratings, default probabilities, and spread analysis for comprehensive credit risk assessment. Understand credit risk with our comprehensive credit analysis and default assessment tools for risk management.
As of April 16, 2026, The Oncology Institute Inc. (TOI) is trading at $3.54, posting an intraday gain of 3.21% during regular market hours. This analysis examines key technical price levels for TOI, recent market context for the specialty oncology care sector, and potential short-term price scenarios that market participants may monitor. No recently released quarterly earnings data is available for TOI at the time of writing, so current price action is largely being driven by technical flows and
The (TOI) Stock: Valuation Metrics (+3.21%) 2026-04-16 - Trending Volume Leaders
TOI - Stock Analysis
3353 Comments
726 Likes
1
Naralee
Returning User
2 hours ago
Looking for like-minded people here.
👍 137
Reply
2
Areya
Regular Reader
5 hours ago
Missed the opportunity… sadly. 😞
👍 282
Reply
3
Myraline
Returning User
1 day ago
So late to the party… 😭
👍 40
Reply
4
Decklen
Expert Member
1 day ago
Timing really wasn’t on my side.
👍 239
Reply
5
Nichel
Legendary User
2 days ago
Timing just wasn’t on my side this time.
👍 195
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.